Mesoblast (MESO) Equity Ratio (2017 - 2022)

Mesoblast's Equity Ratio history spans 6 years, with the latest figure at 0.75 for Q2 2022.

  • For Q2 2022, Equity Ratio fell 3.85% year-over-year to 0.75; the TTM value through Jun 2022 reached 0.75, down 3.85%, while the annual FY2022 figure was 0.75, 3.85% down from the prior year.
  • Equity Ratio for Q2 2022 was 0.75 at Mesoblast, down from 0.78 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.79 in Q2 2018 and bottomed at 0.74 in Q2 2019.
  • The 5-year median for Equity Ratio is 0.75 (2022), against an average of 0.76.
  • The largest annual shift saw Equity Ratio decreased 6.45% in 2019 before it rose 4.26% in 2021.
  • A 5-year view of Equity Ratio shows it stood at 0.79 in 2018, then fell by 6.45% to 0.74 in 2019, then increased by 1.51% to 0.75 in 2020, then grew by 4.26% to 0.78 in 2021, then fell by 3.85% to 0.75 in 2022.
  • Per Business Quant, the three most recent readings for MESO's Equity Ratio are 0.75 (Q2 2022), 0.78 (Q2 2021), and 0.75 (Q2 2020).